Latest Canadian Diabetes Association Stories
Forxiga® (dapagliflozin) approved in Canada - a new treatment that lowers blood glucose and can lead to weight loss(i) and reduced blood pressure for adults living with type 2 diabetes (ii)
MarketReportsOnline.com adds "Global Diabetes Market Report: 2014 Edition" report to its research store. Dallas, TX (PRWEB) November 24, 2014
Denmark's Crown Prince Couple Help Celebrate Canadian, Danish Partnership, Marking Novo Nordisk's 30 Years in Canada MISSISSAUGA, ON, Sept.
Proceeds directly support the Canadian Diabetes Association TORONTO, Aug.
TORONTO, June 27, 2014 /CNW/ - A new partnership between MedicAlert Foundation Canada (MAFCA) and the Canadian Diabetes Association (CDA) means that Canadians living with diabetes will benefit
MISSISSAUGA, ON, June 4, 2014 /CNW/ - Novo Nordisk today announces that the Québec government has approved the inclusion of Victoza(®) (liraglutide), the first once-daily human glucagon-like
INVOKANA((TM) )offers a new approach to treatment TORONTO, May 26, 2014 /CNW/ - Janssen Inc.
A vision for Canadians with diabetes to live to their full potential OTTAWA, April 7, 2014 /CNW/ - The Canadian Diabetes Association (CDA) released the Diabetes Charter for
A vision for Canadians with diabetes to live to their full potential OTTAWA, April 2, 2014 /CNW/ - On April 7, 2014, World Health Day, the Canadian Diabetes Association will
- Withering but not falling off, as a blossom that persists on a twig after flowering.